138 related articles for article (PubMed ID: 21738326)
1. Computer aided screening of inhibitors to 5-α reductase type 2 for prostate cancer.
Bhattacharjee B; Talambedu U; Sadegh S; Goyal AK; Pande V; Nagaveni MB; Patil VM; Jayadev J; Middha SK
Bioinformation; 2011; 6(7):262-5. PubMed ID: 21738326
[TBL] [Abstract][Full Text] [Related]
2. Computational models for 5αR inhibitors for treatment of prostate cancer: review of previous works and screening of natural inhibitors of 5αR2.
Jayadeepa RM; Sharma S
Curr Comput Aided Drug Des; 2011 Dec; 7(4):231-7. PubMed ID: 22050680
[TBL] [Abstract][Full Text] [Related]
3. In silico screening of herbal and nanoparticle lead compounds for effectivity against H5N1, H1N1 neuraminidase and telomerase.
Ganguli S; Mazumder M; Basu P; Roy P; Mitra S; Datta A
BMC Bioinformatics; 2010 Jan; 11 Suppl 1(Suppl 1):S13. PubMed ID: 20122184
[TBL] [Abstract][Full Text] [Related]
4. Review and research analysis of computational target methods using BioRuby and in silico screening of herbal lead compounds against pancreatic cancer using R programming.
Jayadeepa RM; Ray A; Naik D; Sanyal DN; Shah D
Curr Drug Metab; 2014; 15(5):535-43. PubMed ID: 25431153
[TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells.
Tian Y; Zhao L; Wang Y; Zhang H; Xu D; Zhao X; Li Y; Li J
Asian J Androl; 2016; 18(4):607-12. PubMed ID: 26698234
[TBL] [Abstract][Full Text] [Related]
6. Reduced nonprotein thiols inhibit activation and function of MMP-9: implications for chemoprevention.
Pei P; Horan MP; Hille R; Hemann CF; Schwendeman SP; Mallery SR
Free Radic Biol Med; 2006 Oct; 41(8):1315-24. PubMed ID: 17015178
[TBL] [Abstract][Full Text] [Related]
7. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
[TBL] [Abstract][Full Text] [Related]
8. Chemical Characterization,
Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
[TBL] [Abstract][Full Text] [Related]
9. The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet.
Chang YX; Ge AH; Donnapee S; Li J; Bai Y; Liu J; He J; Yang X; Song LJ; Zhang BL; Gao XM
J Ethnopharmacol; 2015 Apr; 164():210-22. PubMed ID: 25698248
[TBL] [Abstract][Full Text] [Related]
10. Hydroxylation of 5 alpha-androstane-3 beta,17 beta-diol by rat prostate microsomes: potent inhibition by imidazole-type antimycotic drugs and lack of inhibition by steroid 5 alpha-reductase inhibitors.
Gemzik B; Parkinson A
Arch Biochem Biophys; 1992 Aug; 296(2):366-73. PubMed ID: 1632630
[TBL] [Abstract][Full Text] [Related]
11. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
[TBL] [Abstract][Full Text] [Related]
12. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
13. Anti cancer activity on Graviola, an exciting medicinal plant extract vs various cancer cell lines and a detailed computational study on its potent anti-cancerous leads.
Paul J; Gnanam R; Jayadeepa RM; Arul L
Curr Top Med Chem; 2013; 13(14):1666-73. PubMed ID: 23889049
[TBL] [Abstract][Full Text] [Related]
14.
Khanam U; Haque S; Somvanshi P; Rathi B
J Microbiol Biotechnol; 2019 Oct; ():. PubMed ID: 31601057
[TBL] [Abstract][Full Text] [Related]
15. Molecular insights of anti-diabetic compounds and its hyaluronic acid conjugates against aldose reductase enzyme through molecular modeling and simulations study-a novel treatment option for inflammatory diabetes.
Jayabal D; Jayanthi S; Thirumalaisamy R; Shimu MSS
J Mol Model; 2023 Jul; 29(8):238. PubMed ID: 37420135
[TBL] [Abstract][Full Text] [Related]
16. mPGES-1 Inhibitor Discovery Based on Computer-Aided Screening: Pharmacophore Models, Molecular Docking, ADMET, and MD Simulations.
Huang Q; Lai T; Wang Q; Luo L
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630311
[TBL] [Abstract][Full Text] [Related]
17. Exploration of Novel 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia by 2D/3D QSAR, Cytotoxicity Pre-ADME and Docking Studies.
Dhingra R; Malhotra M; Sharma V; Bhardwaj TR; Dhingra N
Curr Top Med Chem; 2018; 18(32):2816-2834. PubMed ID: 30659542
[TBL] [Abstract][Full Text] [Related]
18. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
Rastelli G; Ferrari AM; Costantino L; Gamberini MC
Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Ramirez E; Heuze Y; Flores E
Curr Med Chem; 2005; 12(8):927-43. PubMed ID: 15853706
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
